111 related articles for article (PubMed ID: 31648509)
21. Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
Teethaisong Y; Nakouti I; Evans K; Eumkeb G; Hobbs G
J Glob Antimicrob Resist; 2019 Sep; 18():22-25. PubMed ID: 30668995
[TBL] [Abstract][Full Text] [Related]
22. Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection.
Abdallah HM; Wintermans BB; Reuland EA; Koek A; al Naiemi N; Ammar AM; Mohamed AA; Vandenbroucke-Grauls CM
PLoS One; 2015; 10(5):e0128120. PubMed ID: 26001049
[TBL] [Abstract][Full Text] [Related]
23. Impact of short-incubation MALDI-TOF MS on empiric antibiotic therapy in bloodstream infections caused by Pseudomonas aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae.
Halavaara M; Nevalainen A; Martelius T; Kuusela P; Anttila VJ
Diagn Microbiol Infect Dis; 2019 May; 94(1):1-6. PubMed ID: 30554845
[TBL] [Abstract][Full Text] [Related]
24. CHROMagar mSuperCARBA and RAPIDEC® Carba NP test for detection of carbapenemase-producing Enterobacteriaceae.
Garcia-Quintanilla M; Poirel L; Nordmann P
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):77-80. PubMed ID: 29150373
[TBL] [Abstract][Full Text] [Related]
25. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
Lim CL; Spelman D
Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
[TBL] [Abstract][Full Text] [Related]
26. Comparative Study of a Novel Biochemical Assay, the Rapidec Carba NP Test, for Detecting Carbapenemase-Producing Enterobacteriaceae.
Lifshitz Z; Adler A; Carmeli Y
J Clin Microbiol; 2016 Feb; 54(2):453-6. PubMed ID: 26582833
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
28. Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options.
Aslan AT; Akova M
Expert Rev Anti Infect Ther; 2019 Dec; 17(12):969-981. PubMed ID: 31722185
[No Abstract] [Full Text] [Related]
29. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
[TBL] [Abstract][Full Text] [Related]
30. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
[TBL] [Abstract][Full Text] [Related]
31. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
[TBL] [Abstract][Full Text] [Related]
32. Bloodstream infections caused by multidrug-resistant Enterobacteriaceae: report from two Portuguese hospitals.
Fernandes R; Vieira M; Ferraz R; Prudêncio C
J Hosp Infect; 2008 Sep; 70(1):93-5. PubMed ID: 18632185
[No Abstract] [Full Text] [Related]
33. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the rapid carbapenem inactivation method (rCIM): a phenotypic screening test for carbapenemase-producing Enterobacteriaceae.
Muntean MM; Muntean AA; Gauthier L; Creton E; Cotellon G; Popa MI; Bonnin RA; Naas T
J Antimicrob Chemother; 2018 Apr; 73(4):900-908. PubMed ID: 29351668
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
[TBL] [Abstract][Full Text] [Related]
37. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
Miller S; Humphries RM
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):705-17. PubMed ID: 27348447
[TBL] [Abstract][Full Text] [Related]
38. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
[TBL] [Abstract][Full Text] [Related]
39. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
[TBL] [Abstract][Full Text] [Related]
40. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]